Targeted Oncology: Kaklamani’s Insights on the EMERALD Trial and Elacestrant in Advanced Breast Cancer

Virginia Kaklamani, MD, clinical professor, Department of Medicine, Division of Hematology and Oncology, and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was quoted in this article.

 

Read More

 



Share This Article!